Abstract 4099: Dual targeting of tumor cells and cancer associated fibroblasts enhances CAR T efficacy in solid tumors
Bo Huang(Purdue University West Lafayette), Philip S. Low(Purdue University West Lafayette), Madduri Srinivasarao(Purdue University West Lafayette), Md. Sazzadul Bari(University of Dhaka), Byoung Y. Ryu(CTI BioPharma (United States)), Laurie Beitz(Seattle Children's Hospital), Andrew M. Scharenberg(CTI BioPharma (Italy)), Ramesh Mukkamala(Purdue University West Lafayette), Sudarsan R. Kasireddy(Purdue University West Lafayette), Yashapal Singh(Purdue University West Lafayette), Suilan Zheng(Purdue University West Lafayette), Suresh K. Bowroju(Purdue University West Lafayette), Haiyan Chu, Michael C. Jensen(Seattle Children's Hospital)
Cited by 0
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
|Blood|2017|1.1k
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902